Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Steroids and Extended Anti-Venom in Pediatric Scorpion Stings
NCT06838715Not yet recruiting
- Sponsor
- Assiut University
- Start
- May 2025
- Primary completion
- Apr 2026
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dexamethasone and Scorpion Antivenom in scorpion envenomation (4 arms), sponsored by Assiut University. Primary endpoint: Safety and Tolerability of steroids and anti-venom regimen at 7 days. Planned start May 2025; status: not yet recruiting.
02
Drugs
dexamethasoneScorpion Antivenom
03
Conditions
scorpion envenomation
Beyond the preview
Go deeper on NCT06838715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06838715.